PFPT
MYGN icon

Pinnacle Financial Partners (Tennessee)’s Myriad Genetics MYGN Stock Holding History

Pinnacle Financial Partners (Tennessee)’s Portfolio MYGN Stock Details MYGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-230
Closed -$5K – 191
2013
Q3 		$5K Hold
230
– – ﹤0.01% 193
2013
Q2 		$6K Buy
+230
New +$6.67K ﹤0.01% 178

Other funds holding MYGN

RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
BTS
BB&T Securities Richmond, Virginia $10.9B AUM 5.31% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
LCG
Luxor Capital Group New York $1.43B AUM 30.88% 1-Year Est. Return
MCM
Munder Capital Management Birmingham, Michigan $13.4B AUM 18.35% 1-Year Est. Return
SCM
Sterling Capital Management Charlotte, North Carolina $5.28B AUM 23.15% 1-Year Est. Return
FTCM
Fir Tree Capital Management New York $21.8M AUM 1.61% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Pinnacle Financial Partners (Tennessee)'s MYGN Position: Q4 2013 in Review

Pinnacle Financial Partners (Tennessee) sold out of Myriad Genetics (MYGN) in Q4 2013, closing a stake of 230 shares — an estimated $5K sold.

Pinnacle Financial Partners (Tennessee) first reported a position in MYGN in Q2 2013 and held it in 2 quarters. The position peaked at $6K in Q2 2013. 270 funds tracked by Wall St. Rank hold MYGN as of Q4 2013.

  • Pinnacle Financial Partners (Tennessee) reported no remaining Myriad Genetics position as of Q4 2013 after selling out during the quarter.
  • Pinnacle Financial Partners (Tennessee) sold 230 Myriad Genetics shares in Q4 2013, an estimated $5K.
  • Pinnacle Financial Partners (Tennessee) first reported a position in Myriad Genetics in Q2 2013 and held it in 2 quarters.
  • Pinnacle Financial Partners (Tennessee)'s Myriad Genetics position peaked at $6K in Q2 2013.
  • 270 funds tracked by Wall St. Rank held Myriad Genetics as of Q4 2013.

Based on Pinnacle Financial Partners (Tennessee)'s 13F filing for Q4 2013, filed 10 Feb 2014.